NASDAQ · Biotechnology
Acurx Pharmaceuticals LLC (ACXP)
$1.04
-2.80%
27
Oversold
Moving averages
SMA 200$2.10-50.48%
Company profile
Acurx Pharmaceuticals, LLC, a clinical-stage biopharmaceutical company, develops antibiotics to treat bacterial infections. The company is headquartered in Staten Island, New York.
SectorHealthcare
IndustryBiotechnology
Market cap$7.12M
P/E ratioNone
EPS$-2.67
Beta-2.05
Dividend yield0.00%
52-week high$7.81
52-week low$1.20
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 41
VRTX
Vertex Pharmaceuticals Inc
RSI 68
CRSP
CRISPR Therapeutics AG
RSI 48
IOVA
Iovance Biotherapeutics Inc
RSI 30
SNGX
Soligenix Inc
RSI 48
IMNN
Imunon Inc
RSI 36
SKYE
Skye Bioscience Inc
RSI 31
PHIO
Phio Pharmaceuticals Corp
RSI 37
KTTA
Pasithea Therapeutics Corp
RSI 34
BCDA
BioCardia Inc
RSI 38
RSI alerts for ACXP
An email when ACXP closes below RSI 30 or above 70. Nothing else.
Add alertData last updated 13 October 2026 at 10:07 PM EDT